Advertisements



The Week Ahead In Biotech: Conferences, Clinical Trials And IPOs

The ASCO conference closed Tuesday, although presentations at the conference triggered some huge stocks moves. read more.....»»

Category: blogSource: benzingaJun 10th, 2018

The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs

Biotech earnings news flow accelerated in last week, with Pfizer Inc. (NYSE: PFE) and Sanofi SA (NYSE: SNY) among the noteworthy releases of the week. With the earnin.....»»

Category: earningsSource: benzingaNov 4th, 2018

The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs

Biotech earnings news flow accelerated in last week, with Pfizer Inc. (NYSE: PFE) and Sanofi SA (NYSE: SNY) among the noteworthy releases of the week. read more.....»»

Category: blogSource: benzingaNov 4th, 2018

The Week Ahead In Biotech: Conferences, Clinical Trial Results And IPOs

As we step into the final quarter of 2018, biotech stocks have recorded double-digit gains for the year-to-date period. Will the run up continue? Stay tuned to the following events of the upcoming week. read more.....»»

Category: blogSource: benzingaOct 8th, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results And IPOs

After ending almost flat in the week ended Sept. 14, biotech stocks have seen some bounce in the running week, with the iShares NASDAQ Biotechnology Index (NASDAQ: IBB) up about 1.3 percent through Thursday. read more.....»»

Category: blogSource: benzingaSep 24th, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results And IPOs

After ending almost flat in the week ended Sept. 14, biotech stocks have seen.....»»

Category: earningsSource: benzingaSep 24th, 2018

The Week Ahead In Biotech (Sept. 23-29): Conferences, PDUFA Dates, Clinical Trial Results And IPOs

After ending almost flat in the week ended Sept. 14, biotech stocks have seen some bounce in the running week, with the iShares NASDAQ Biotechnology Index (NASDAQ: IBB) up about 1.3 percent through Thursday. read more.....»»

Category: blogSource: benzingaSep 23rd, 2018

The Week Ahead In Biotech (Sept. 23-29): Conferences, PDUFA Dates, Clinical Trial Results And IPOs

After ending almost flat in the week ended Sept. 14, .....»»

Category: earningsSource: benzingaSep 23rd, 2018

The Week Ahead In Biotech (Sept. 16-22): Conferences, PDUFA Dates, Clinical Trial Results And IPOs

Biotech were trending mostly sideways in the week ending Sept. 14 after posting weekly gains in the previous two weeks. Notwithstanding the overall muted sentiment, there was some activity in reaction to the release of clinical trial results. read more.....»»

Category: blogSource: benzingaSep 16th, 2018

The Week Ahead In Biotech: Conferences, Clinical Trial Results, Earnings And IPOs

After recording stellar gains of 4.3 percent in the week ended Aug. 31 to close the month in the green, the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) saw a moderation in momentum in the holiday-shortened week ending Sept. 7. read more.....»»

Category: blogSource: benzingaSep 9th, 2018

The Week Ahead In Biotech: Conferences, Clinical Trial Results, Earnings And IPOs

After recording stellar gains of 4.3 percent in the week ended Aug. 31 to close the month .....»»

Category: earningsSource: benzingaSep 9th, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings

The biotech sector notched strong gains last week, capitalizing on the positive overall mark.....»»

Category: earningsSource: benzingaSep 2nd, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings

The biotech .....»»

Category: blogSource: benzingaSep 2nd, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings And IPOs

Biotech stocks saw modest gains this week, with earnings providing a boost even as clinical trial results elicited a mixed reaction. read more.....»»

Category: blogSource: benzingaJul 28th, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings And IPOs

Biotech stocks saw modest gains this week, with earnings providing a boost even as clinical trial results elicited a mixed reaction. Eli Lilly And Co (NYSE: LLY), Vertex Pharmaceuticals Incorporated (NA.....»»

Category: earningsSource: benzingaJul 28th, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results, Earnings And IPOs

The upcoming week could see some action due to the presence of a host of catalytic events that include PDUFA dates and earnings releases. Here are are the ones a biotech investor should keep a tab on. read more.....»»

Category: blogSource: benzingaJul 22nd, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results, Earnings And IPOs

The upcoming week could see some action due to the presence of a host of catalytic events that include PDUFA dates and earnings releases. Here are are the ones a biotech investor should keep a tab on. Conferences Alzheimer's Association In.....»»

Category: earningsSource: benzingaJul 22nd, 2018

The Week Ahead In Biotech: Conferences, Clinical Trial Results, IPOs And More

A bit of a lull took place in the biotech space ahead of earnings season; IPO activity was non-existent, but there was some action on account of clinical trial results. He.....»»

Category: earningsSource: benzingaJul 14th, 2018

The Week Ahead In Biotech: Conferences, Clinical Trial Results, IPOs And More

A bit of a lull took place in the biotech space ahead of earnings season; IPO activity was non-existent, but there was some action on account of clinical trial results. Here's a look at the upcoming week's catalytic events. read more.....»»

Category: blogSource: benzingaJul 14th, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials

Biotech stocks held their ground in a holiday-shortened week amid a drought of market-moving catalysts. Looking ahead, the following are catalytic events for biotech investors to watch.  read more.....»»

Category: blogSource: benzingaJul 8th, 2018

The Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results, Large-Cap Pharma Earnings And IPOs

Biotech stocks are staging a rebound following the losses incurred in the week ended Oct. 12 amid catalysts that include the third-quarter earnings s.....»»

Category: earningsSource: benzingaOct 21st, 2018